Predicting the Safety and Effectiveness of Inferior Vena Cava Filters

CompletedOBSERVATIONAL
Enrollment

1,428

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

March 17, 2020

Study Completion Date

September 20, 2021

Conditions
Pulmonary EmbolismDeep Vein Thrombosis
Interventions
DEVICE

IVC Filter

Trial Locations (53)

10029

Mount Sinai Hospital, New York

10065

Memorial Sloan Kettering Cancer Center, New York

NY Presbyterian Weil Cornell Medical Ctr, New York

11030

Feinstein Institute, Manhasset

12208

Albany Medical Center, Albany

13210

University Hospital/SUNY Upstate, Syracuse

14621

Rochester Regional Health System, Rochester

15213

University of Pittsburgh Medical Center, Pittsburgh

19104

Hospital of the University of Pennsylvania, Philadelphia

20007

Medstar Georgetown, Washington D.C.

22042

Inova Fairfax Hospital, Falls Church

27157

Wake Forest Baptist Health, Winston-Salem

27710

Duke Medical Center, Durham

28203

Carolinas Medical Center, Charlotte

29303

Spartanburg Regional Medical Center, Spartanburg

32308

Tallahasse Memorial Hospital, Tallahassee

32803

Florida Hospital, Orlando

33136

University of Miami Hospital and Clinics/Jackson Memorial, Miami

33301

Holy Cross Hospital, Fort Lauderdale

33407

St. Mary's Medical Center, West Palm Beach

33770

The Heart Institute Largo, Largo

34239

Sarasota Memorial Hospital, Sarasota

43130

Fairfield Medical Center, Lancaster

44195

Cleveland Clinic, Cleveland

45409

Miami Valley Hospital/Wright State University, Dayton

46202

Indiana University, Indianapolis

48073

William Beaumont Hospital, Royal Oak

48109

University of Michigan, Ann Arbor

53226

Medical College of WI/Froedtert Memorial Lutheran Hospital, Milwaukee

55455

University of Minnesota, Minneapolis

55905

Mayo Clinic, Rochester

60611

Northwestern Memorial Hospital, Chicago

61801

Carle Heart & Vascular Institute, Urbana

63110

St. Louis University, St Louis

Washington University, St Louis

71130

LSU Health Sciences Center at Shreveport, Shreveport

72205

University of Arkansas, Little Rock

74104

University of Oklahoma-Tulsa, Tulsa

75390

UT Southwestern, Dallas

77030

Memorial Hermann Hospital, Houston

80045

University of Colorado, Aurora

90024

Ronald Regan UCLA Medical Center, Los Angeles

90502

Harbor-UCLA Medical Center, Torrance

94118

University of California San Francisco, San Francisco

94304

Palo Alto VA, Palo Alto

97239

Oregon Health & Science Center, Portland

06501

Yale New Haven Hospital, New Haven

02118

Boston Medical Center, Boston

02446

Massachusetts General Hospital, Boston

02747

Southcoast Hospital, North Dartmouth

07601

Hackensack UMC, Hackensack

07901

Overlook Medical Center, Summit

02903

Rhode Island Hospital/Miriam Hospital, Providence

All Listed Sponsors
collaborator

ALN Implants Chirurgicaux

UNKNOWN

collaborator

B. Braun Interventional Systems, Inc

INDUSTRY

collaborator

Bard Peripheral Vascular, Inc.

INDUSTRY

collaborator

Cook Group Incorporated

INDUSTRY

collaborator

Cordis Corporation

INDUSTRY

collaborator

Argon Medical Devices

INDUSTRY

collaborator

Society of Interventional Radiology Foundation

OTHER

collaborator

Society for Vascular Surgery

OTHER

lead

Carelon Research

OTHER

NCT02381509 - Predicting the Safety and Effectiveness of Inferior Vena Cava Filters | Biotech Hunter | Biotech Hunter